Skip to main content
. 2015 Jul 16;10(7):e0132580. doi: 10.1371/journal.pone.0132580

Fig 6. Anxa3 gain-of-function has no effect on developing blood vessels in vivo.

Fig 6

(A,B) Whole-mount in situ hybridization for Aplnr expression in GFP and Anxa3 mRNA injected embryos (stage 34, lateral views). No changes in overall vessel morphology or levels of Aplnr expression were observed. (C) The percent (%) of GFP and Anxa3 mRNA injected embryos displaying normal vascular formation, as assessed by Aplnr expression, are shown. Aortic arches, aa; intersomitic vessel, isv; n, number of embryos assayed; posterior cardinal vein, pcv and vascular plexus, vp.